Correlation Between Adial Pharmaceuticals and Ocuphire Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adial Pharmaceuticals and Ocuphire Pharma, you can compare the effects of market volatilities on Adial Pharmaceuticals and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Ocuphire Pharma.

Diversification Opportunities for Adial Pharmaceuticals and Ocuphire Pharma

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Adial and Ocuphire is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Ocuphire Pharma go up and down completely randomly.

Pair Corralation between Adial Pharmaceuticals and Ocuphire Pharma

If you would invest  113.00  in Ocuphire Pharma on August 27, 2024 and sell it today you would earn a total of  0.00  from holding Ocuphire Pharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Adial Pharmaceuticals  vs.  Ocuphire Pharma

 Performance 
       Timeline  
Adial Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Adial Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward indicators, Adial Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Ocuphire Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocuphire Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest inconsistent performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Adial Pharmaceuticals and Ocuphire Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adial Pharmaceuticals and Ocuphire Pharma

The main advantage of trading using opposite Adial Pharmaceuticals and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.
The idea behind Adial Pharmaceuticals and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance